Whether liver transplantation can be performed for advanced hepatocellular carcinoma and how long one can live after transplantation still need to take into account the actual situation of the patient, whether the patient’s liver transplantation is alive or not, and whether there is recurrence after transplantation.
Patients with hepatocellular carcinoma who have large vascular thrombosis or lymph node metastasis should not undergo liver transplantation. Tumors located in the left lobe or both lobes of the liver, tumors with disseminated foci, and preoperative methemoglobin testing of 300 mg/L suggest a poor prognosis and a high rate of metastasis and recurrence after liver transplantation, and liver transplantation should not be performed in these cases. The use of liver transplantation as an effective treatment for patients with liver cancer has given hope to patients and families, but there are still a significant number of patients with recurrent metastases after liver transplantation, and liver transplantation itself is costly and difficult to find liver donors, which can be even more devastating to patients and families once they recur.
How long a patient can live after liver cancer transplantation depends on the control of the indications, the source of the liver, whether rejection after surgery, whether recurrence, etc. If the surgery is very successful after transplantation and rejection is mild or absent, then the patient can achieve normal survival, and if rejection is large or recurrence occurs within 2 years, then it will affect the patient’s life.